Thought Leadership

FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

District of Delaware Finds Allergan Patents Invalid for Lack of Written Description and Obviousness-Type Double Patenting in Allergan v. MSN Labs

Legal Alert: EPO Enlarged Board of Appeal Raises Bar for Challenging Priority Claims at the EPO 

Texas Patent Litigation Monthly Wrap-Up: October 2023

District of Delaware Finds Non-Orange Book-Listed Patents Subject to the Same Pleading Standard as Listed Patents in ANDA Infringement Suit

USPTO Issues Proposed Rules on Pre-Issuance Internal Circulation and Review of PTAB Decisions

Eleven Ways the PREVAIL Act Would Alter PTAB Practice

ITC Monthly Wrap-Up: September 2023

What’s New in Director Review?

Federal Circuit Evaluates Enablement for Antibody Claims for the First Time Since Amgen v. Sanofi in Baxalta Inc. et al. v. Genentech, Inc.

TTAB Rules Consumer Perception Remains the Critical Inquiry for Generic.gTLD Marks

ITC Monthly Wrap-Up: August 2023